Evidence map›Paper›PMID 27479005›Full record

ArticlePloS one2016

New Perspectives on Ebola Virus Evolution.

Celeste J Brown, Caleb J Quates, Christopher A Mirabzadeh, Craig R Miller, Holly A Wichman, Tanya A Miura, F Marty Ytreberg

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 93% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Celeste J BrownDepartment of Biological Sciences, University of Idaho, Moscow, Idaho, United States of America.
Caleb J QuatesCenter for Modeling Complex Interactions, University of Idaho, Moscow, Idaho, United States of America.
Christopher A MirabzadehCenter for Modeling Complex Interactions, University of Idaho, Moscow, Idaho, United States of America.
Craig R MillerDepartment of Biological Sciences, University of Idaho, Moscow, Idaho, United States of America.
Holly A WichmanDepartment of Biological Sciences, University of Idaho, Moscow, Idaho, United States of America.
Tanya A MiuraDepartment of Biological Sciences, University of Idaho, Moscow, Idaho, United States of America.
F Marty YtrebergInstitute for Bioinformatics and Evolutionary Studies, University of Idaho, Moscow, Idaho, United States of America.
University of Idaho · US

Funding

Sequence-structure-function relationships in human visual photopigmentsP20GM104420 · NIGMS · UNIVERSITY OF IDAHO · PI WICHMAN, HOLLY A · 2015 to 2024
$22.9M
Genomics Resources Core (GRC)P30GM103324 · NIGMS · UNIVERSITY OF IDAHO · PI SETTLES, MATTHEW · 2013 to 2017
$5.0M
NIGMS NIH HHS P20 GM104420NIGMS NIH HHS P30 GM103324
6 · The paper itself

Abstract

Since the recent devastating outbreak of Ebola virus disease in western Africa, there has been significant effort to understand the evolution of the deadly virus that caused the outbreak. There has been a considerable investment in sequencing Ebola virus (EBOV) isolates, and the results paint an important picture of how the virus has spread in western Africa. EBOV evolution cannot be understood outside the context of previous outbreaks, however. We have focused this study on the evolution of the EBOV glycoprotein gene (GP) because one of its products, the spike glycoprotein (GP1,2), is central to the host immune response and because it contains a large amount of the phylogenetic signal for this virus. We inferred the maximum likelihood phylogeny of 96 nonredundant GP gene sequences representing each of the outbreaks since 1976 up to the end of 2014. We tested for positive selection and considered the placement of adaptive amino acid substitutions along the phylogeny and within the protein structure of GP1,2. We conclude that: 1) the common practice of rooting the phylogeny of EBOV between the first known outbreak in 1976 and the next outbreak in 1995 provides a misleading view of EBOV evolution that ignores the fact that there is a non-human EBOV host between outbreaks; 2) the N-terminus of GP1 may be constrained from evolving in response to the host immune system by the highly expressed, secreted glycoprotein, which is encoded by the same region of the GP gene; 3) although the mucin-like domain of GP1 is essential for EBOV in vivo, it evolves rapidly without losing its twin functions: providing O-linked glycosylation sites and a flexible surface.

Indexed as

Evolution, MolecularAfrica, WesternAmino Acid SequenceDisease OutbreaksEbolavirusGlycoproteinsGlycosylationHemorrhagic Fever, EbolaHumansMutagenesis, Site-DirectedPhylogenyProtein Structure, TertiaryViral Envelope ProteinsGlycoproteinsViral Envelope Proteins

Identifiers

PMID27479005
PMCPMC4968807
OpenAlexW2501894396

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.